BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 14678011)

  • 21. Increased expression of deltaCaMKII isoforms in skeletal muscle regeneration: Implications in dystrophic muscle disease.
    Abraham ST; Shaw C
    J Cell Biochem; 2006 Feb; 97(3):621-32. PubMed ID: 16215994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.
    Tutdibi O; Brinkmeier H; Rüdel R; Föhr KJ
    J Physiol; 1999 Mar; 515 ( Pt 3)(Pt 3):859-68. PubMed ID: 10066910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diaphragm tension reduced in dystrophic mice by an oxidant, hypochlorous acid.
    Lafoux A; Divet A; Gervier P; Huchet-Cadiou C
    Can J Physiol Pharmacol; 2010 Feb; 88(2):130-40. PubMed ID: 20237587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient receptor potential cation channels in normal and dystrophic mdx muscle.
    Krüger J; Kunert-Keil C; Bisping F; Brinkmeier H
    Neuromuscul Disord; 2008 Jun; 18(6):501-13. PubMed ID: 18504127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
    Beard NA; Laver DR; Dulhunty AF
    Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
    Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
    Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
    Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
    J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium entry through stretch-inactivated ion channels in mdx myotubes.
    Franco A; Lansman JB
    Nature; 1990 Apr; 344(6267):670-3. PubMed ID: 1691450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E; Pennington C; Isales CM; Hamrick MW
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcellular fractionation of dystrophin to the triads of skeletal muscle.
    Hoffman EP; Knudson CM; Campbell KP; Kunkel LM
    Nature; 1987 Dec 24-31; 330(6150):754-8. PubMed ID: 2447503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Greater susceptibility of the sarcoplasmic reticulum to H2O2 injuries in diaphragm muscle from mdx mice.
    Lafoux A; Divet A; Gervier P; Huchet-Cadiou C
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1359-67. PubMed ID: 16801456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscle.
    Kargacin ME; Kargacin GJ
    Biochim Biophys Acta; 1996 May; 1290(1):4-8. PubMed ID: 8645705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca2+ sparks as a plastic signal for skeletal muscle health, aging, and dystrophy.
    Weisleder N; Ma JJ
    Acta Pharmacol Sin; 2006 Jul; 27(7):791-8. PubMed ID: 16787561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calsequestrin expression and calcium binding is increased in streptozotocin-induced diabetic rat skeletal muscle though not in cardiac muscle.
    Howarth FC; Glover L; Culligan K; Qureshi MA; Ohlendieck K
    Pflugers Arch; 2002 May; 444(1-2):52-8. PubMed ID: 11976916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain dystrophin-glycoprotein complex: persistent expression of beta-dystroglycan, impaired oligomerization of Dp71 and up-regulation of utrophins in animal models of muscular dystrophy.
    Culligan K; Glover L; Dowling P; Ohlendieck K
    BMC Cell Biol; 2001; 2():2. PubMed ID: 11178104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.
    Iwata Y; Katanosaka Y; Shijun Z; Kobayashi Y; Hanada H; Shigekawa M; Wakabayashi S
    Biochem Pharmacol; 2005 Sep; 70(5):740-51. PubMed ID: 16009351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanosensitive ion channels in skeletal muscle: a link in the membrane pathology of muscular dystrophy.
    Lansman JB; Franco-Obregón A
    Clin Exp Pharmacol Physiol; 2006 Jul; 33(7):649-56. PubMed ID: 16789935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.
    Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S
    Hum Mol Genet; 2009 Mar; 18(5):824-34. PubMed ID: 19050039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of diltiazem or verapamil on calcium uptake and release from chicken skeletal muscle sarcoplasmic reticulum.
    Paydar MJ; Pousti A; Farsam H; Amanlou M; Mehr SE; Dehpour AR
    Can J Physiol Pharmacol; 2005 Nov; 83(11):967-75. PubMed ID: 16391705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.